论文部分内容阅读
阿克拉霉素ACM胸腔内注入治疗癌性胸水7例其中原发肿瘤为肺癌4例,胃癌、胆管细胞癌和恶性胸膜间皮瘤各一例,年龄在40～76岁之间,其中男3例,女4例。胸腔低压持续吸引尽可能地排除胸内积液。待肺充分膨张后,将ACM100mg+生理盐水100ml注入胸腔。尔后,封闭排液导管,进行充分的体位变换,约待4小时后,胸腔内为-15cmH_2O的负压时,再行持续吸引,直至排除的胸水量每日为20～30ml时为止。临床实验表明,此种方法治疗癌性胸水效果良好,7例中有5例持续3个月以上无胸水,1例一个月以上无胸水,另有一例胸水减少,肿瘤细胞消失,有效率达86％。
Acute clarithromycin ACM injection of pleural effusion in 7 cases of malignant pleural effusion in which the primary tumor in 4 cases of lung cancer, gastric cancer, cholangiocarcinoma and malignant pleural mesothelioma in each case, aged 40 to 76 years old, including 3 males , Female 4 cases. Chest pressure continued to attract as much as possible to rule out intracranial fluid. To be fully expanded lungs, the ACM100mg + saline 100ml into the chest. Then, close the drainage catheter, the full body position change, about 4 hours later, the chest when the negative pressure of -15cmH2O, and then continued to attract until the exclusion of hydrothorax daily up to 20 ~ 30ml so far. Clinical trials show that this method is effective in treating malignant pleural effusion, 5 of 7 cases last for more than 3 months without pleural effusion, 1 case of pleural effusion more than one month without pleural effusion, another case of pleural effusion, tumor cells disappear, the effective rate of 86 %.